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Iceland, Norway, and Switzerland for the year 2010, and to 
investigate potential influencing factors. The 1-year preva-
lence of AD in the EU was estimated at 3.4% among people 
18–64 years of age in Europe (women 1.7%, men 5.2%), re-
sulting in close to 11 million affected people. Taking into ac-
count all people of all ages, AD, abuse and harmful use re-
sulted in an estimate of 23 million affected people. Preva-
lence of AD varied widely between European countries, and 
was significantly impacted by drinking cultures and social 
norms. Correlations with level of drinking and other drinking 
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 Abstract 
 Alcohol use disorders (AUDs), and alcohol dependence (AD) 
in particular, are prevalent and associated with a large bur-
den of disability and mortality. The aim of this study was 
to  estimate prevalence of AD in the European Union (EU), 
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variables and with major known outcomes of heavy drink-
ing, such as liver cirrhosis or injury, were moderate. These 
results suggest a need to rethink the definition of AUDs. 
 © 2014 S. Karger AG, Basel 
 Introduction 
 Alcohol consumption is a major risk factor for the bur-
den of disease  [1–3] . Alcohol use disorders (AUDs), as 
defined by the Diagnostic and Statistical Manual of Men-
tal Disorders (DSM) version IV  [4] or the 10th revision 
of the International Statistical Classification of Diseases 
and Related Health Problems (ICD-10)  [5] , are associated 
with the most detrimental health consequences caused 
by  alcohol consumption  [6–9] . For instance, for the 
 European Union (EU) in 2004, alcohol dependence (AD), 
the most severe form of AUDs, was estimated to be re-
sponsible for more than 60% of all alcohol-attributable 
mortality, causing 85,000 deaths (12,000 deaths among 
women and 73,000 deaths among men)  [10, 11] .
 Estimates of the burden caused by AUDs are usually 
based on attributable fractions and require information 
on the prevalence of AUDs and the relative risk for out-
comes causally related to AUDs ( [12] ; for disease-specif-
ic relative risks associated with AUDs, see  [13] ). Thus, 
reliable and valid data on the prevalence of AD and al-
cohol abuse (DSM-IV) or the harmful use of alcohol 
(ICD-10) would be required to measure and monitor the 
prevalence of AUDs and their consequences (no 
 European studies were available up to 2013 using DSM-
5). As the last systematic epidemiologic review of AUDs 
in Europe was published in 2005  [14] , it is the aim of this 
study to present an overview of current knowledge on 
the prevalence of AD and AUDs in the EU-27 and the 
other European ALICE-RAP participating countries 
(Iceland, Norway and Switzerland). We will examine the 
availability, validity, and reliability of the currently avail-
able data. We will also analyze potential covariates and 
influencing factors.
 Large comparative international studies by the World 
Health Organization (WHO) on the validity and reliabil-
ity of diagnostic categories in ten countries showed that 
the diagnostic concordance coefficients between the usu-
al instruments used to measure AUDs and psychiatric 
judgments were good to very good for dependence, but 
considerably lower for the abuse and harmful use  [15, 16] . 
This finding has been corroborated by other studies  [17] . 
Thus, this study focuses on AD as the most severe  [18, 19] 
and valid sub-diagnosis of AUDs.
 Methods 
 Selection of Studies for Prevalence Data and the Derivation of 
Prevalence Estimates 
 Prevalence estimates for AD were based on an earlier system-
atic literature review for each country examined ( [10] , updated to 
September 2013 based on the latest WHO Global Status Report on 
Alcohol and Health  [20] ), to obtain best estimates for 2010. The 
data obtained from the systematic review were then adjusted for 
biases and checked for validity and comprehensiveness by the Ad-
diction and Lifestyles in Contemporary Europe-Reframing Addic-
tions Project (ALICE-RAP) experts in all participating countries.
 The following selection criteria for prevalence estimates of AD 
were used: the highest priority was given to prevalence estimates 
obtained from nationally representative surveys of the general 
population that used a standardized and validated instrument to 
measure AD, such as the Composite International Diagnostic In-
terview (CIDI  [21] ) or the Schedules for Clinical Assessment in 
Neuropsychiatry (SCAN  [22] ) in its various forms (for reliability 
and validity of these instruments to assess AD, see  [15, 16] ). With-
in this category, we preferred studies where the prevalence of AD 
and alcohol abuse/harmful use was assessed independently.
 The second highest priority was given to prevalence estimates 
for AD that were obtained from nationally representative surveys 
of the general population using a standardized and validated in-
strument where AD and alcohol abuse/harmful use were not as-
sessed independently. Most importantly in this category, the early 
round of the World Mental Health Survey in European countries 
 [23] assessed AD only if at least one criterion for alcohol abuse was 
fulfilled; as a consequence, the prevalence of AD was severely un-
derestimated by the World Mental Health Surveys (WMHS)  [24] . 
The WMHS were used in estimating AD for Belgium (part of the 
overall estimate; see  table 1 ), Bulgaria (see also  [25, 26] , for details 
on the operationalization), the Czech Republic  [27] , France, Italy 
 [28] , Romania  [29] and Spain  [30] . For each of these countries the 
prevalence estimates had to be adjusted as these empirical esti-
mates were severely underestimated; only people with a symptom 
of alcohol abuse were screened for AD. These prevalence estimates 
were adjusted by upshifting the empirical prevalence by the pro-
portion of overall AD, where no symptoms of alcohol abuse were 
observed (based on data from the German National Health Inter-
view and Examination Survey  [31, 32] ). For countries in Central 
or Eastern Europe, the Slovakian WHO Multi-Country Survey 
Study  [33] was used for upshifting. While this procedure could be 
seen as correcting the underestimation of AD, it may have been too 
conservative a method for countries in the South of Europe where 
AD is relatively more prevalent than alcohol abuse because of these 
countries’ drinking patterns  [10] .
 The third highest priority was given to national prevalence es-
timates of AD that were accompanied (either directly or indirect-
ly) by a clear description of the methodology used (for an example, 
see Switzerland  [34] ). The lowest priority was given to prevalence 
estimates obtained from national or international organizations 
that were not accompanied (neither directly nor indirectly) by a 
clear indication of sources or of the methodology used (e.g. from 
the WHO or the EU, e.g. http://ec.europa.eu/health/alcohol/ 
policy/country_profiles/ based on  [35] ; see  table  1 ). If only the 
prevalence of AUDs was presented, these figures were adjusted as 
to only report the prevalence of AD based on the relative preva-
lence of AUD and AD observed for neighboring countries. Not 
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 Table 1.  Prevalence and number of people 18–64 years of age with AD (best estimate 2010)
Country Prevalence of AD, % Year Number of people who were  
alcohol-dependent (2010)
Source
women men total w omen men total
Austria 3.0 8.8 5.9 2004 79,700 235,700 315,400 [39]; this prevalence was derived from an overall prevalence 
of AD for Austria, and it was assumed that the age pattern 
in Austria followed the pattern in Germany [40]
Belgium1 2.3 6.3 4.3 2001/2002 76,300 211,000 287,300 Mean of two major surveys in 1 year (WMHS adjusted and 
Belgian Health Survey 2001, cf. GSRA); original age range 
corrected
Bulgaria 0.4 4.3 2.3 2003–2007 8,700 104,900 113,600 Data were part of WMHS; adjusted for methodological 
problems with algorithm for asking dependence; for a 
documentation of fieldwork [25, 26]; age range 18–79 in 
original study
Cyprus 1.6 5.3 3.5 2004 5,600 20,000 25,600 Data from EU: http://ec.europa.eu/health/alcohol/policy/
country_profiles/based on [35]
Czech Republic 0.8 5.0 2.9 1989–1999 28,000 178,700 206,700 WMHS; adjusted for methodological problems with 
algorithm for asking dependence [27]; age range 18–79 in 
original study
Denmark 2.2 5.6 3.9 2005 37,400 96,600 134,000 [94]; estimation taken into consideration adjustment for 
non-participation; 16+ population of Denmark in the 
original study was converted for 18- to 64-year-olds
Estonia 1.4 13.0 7.0 1999 6,300 53,600 59,900 [95]; no clear indication about age range in the original 
publication, so we assumed 18- to 64-year-olds
Finland 1.9 7.2 4.6 2000 31,500 121,900 153,400 [96] for under 30-year-olds; [97] for 30- to 64-year-olds 
[see also 98]
France 1.5 5.3 3.4 2001–2002 290,500 1,012,300 1,302,800 WMHS, adjusted for methodological problems with 
algorithm for asking dependence; original age range 
corrected [see also 99]
Germany2 2.0 5.0 3.6 2009–2012 514,100 1,311,200 1,825,300 Mean of German Epidemiological Survey of Substance 
Abuse; ages 18–64 with n = 9,084 [53], and the German 
National Health Interview and Examination Survey for 
Adults conducted 2009–2012, age group 18–79 with 5,318 
respondents [40, 100, 101]. For the latter survey, only the age 
groups 18–64 were used. Germany is the country with the 
most surveys on AD in Europe (see footnote 1 to the table)
Greece 1.5 4.8 3.2 2004 53,800 176,400 230,200 Data from EU: http://ec.europa.eu/health/alcohol/policy/
country_profiles/ based on [35]
Hungary 3.7 10.1 6.8 2010 121,000 323,700 444,700 Hungarian Statistical Office; http://www.ksh.hu/; based on 
a version of the Jellinek formula; adjusted for age pattern of 
Bulgaria
Iceland 0.7 10.5 5.7 2005–2007 700 10,700 11,400 [102]; based on a census study of the greater Reykjavik area 
with sampling of all born in 1931, 1951 and 1971
Ireland 2.0 6.4 4.2 2004 28,100 91,400 119,500 Data from EU: http://ec.europa.eu/health/alcohol/policy/
country_profiles/ based on [35]
Italy3 <1 <1 <1 2001–2003 84,700 86,000 170,700 [28]; WMHS, too small numbers with AD to do proper 
statistical adjustments; the authors found 7 people with 
AUD in a sample of n = 4,712 people aged 18 years and 
older (general population), in the majority people with 
alcohol abuse only
Latvia 4.3 21.2 12.5 2011 32,500 149,300 181,800 [103]; estimate is for people aged 15–64 years 
Lithuania 1.9 9.9 5.8 2004 21,200 102,900 124,100 Data from EU: http://ec.europa.eu/health/alcohol/policy/
country_profiles/ based on [35]
 Alcohol Dependence in Europe Eur Addict Res 2015;21:6–18
DOI: 10.1159/000365284
9
included in our systematic review were prevalence estimates of 
AD that were derived from screening scales such as the Alcohol 
Use Disorders Identification Test (AUDIT)  [36] or the CAGE 
questionnaire  [37] ; however, these estimates are provided as foot-
notes to  table 1 , if no estimate form the highest priority was avail-
able, or used in other parts of the paper (for trends, if there were 
comparable surveys).
 Age Standardization and Estimation of the Number of People 
Affected 
 Population estimates in 5-year intervals were obtained from 
the United Nations 2008 population revisions  [38] . If prevalence 
data for AD were reported by sex and age, we used weighted aver-
ages of the various age groups to formulate population estimates. 
If only estimates of AD for wider age groups (such as for Austria 
 Table 1.  (continued)
Country Prevalence of AD, % Year Number of people who were  
alcohol-dependent (2010)
Source
women men total w omen men total
Luxembourg 1.8 5.2 3.5 2,800 8,700 11,500 Mean of France and Germany
Malta 0.8 2.8 1.8 2004 1,100 4,000 5,100 Data from EU: http://ec.europa.eu/health/alcohol/policy/
country_profiles/ based on [35]
The Netherlands4 0.5 1.0 0.8 2007/2009 26,000 53,100 79,100 [104], 18–64 years old
Norway 1.8 6.1 4.0 1994–1997; 
1997–1999
26,900 95,200 122,100 [52, 105], with the average of Oslo and rural sample taken: 
18–65 years old
Poland5 1.6 8.4 5.0 2004 209,100 1,078,100 1,287,200 Data from EU: http://ec.europa.eu/health/alcohol/policy/
country_profiles/ based on [35]
Portugal6 1.7 5.6 3.6 2004 58,500 188,800 247,300 Data from EU: http://ec.europa.eu/health/alcohol/policy/
country_profiles/ based on [35]
Romania 0.7 2.2 1.5 2005/2006 50,400 156,300 206,700 [29] WMHS, adjusted for methodological problems with 
algorithm for asking dependence
Slovakia 1.3 9.2 5.2 2000/2001 24,400 172,300 196,700 MCSS only age groups 15–64 taken with age-specific 
prevalence weighted by population size
Slovenia 2.0 10.5 6.3 1999 13,300 72,000 85,300 GSRA (adjusted for screening scale), taken from [14]
Spain 0.2 1.2 0.7 2000/2001 29,700 182,400 212,100 WMHS, adjusted for methodological problems with 
algorithm for asking dependence
Sweden7 3.8 6.4 5.1 2003–2007 107,300 186,400 293,700 [106]; only age groups 18–65 taken
Switzerland 1.6 8.1 4.9 2007 39,400 200,900 240,300 [34]
UK 
(England only)8
3.9 9.9 6.9 2007 755,000 1,907,100 2,662,100 [55] https://catalogue.ic.nhs.uk/publications/mental-
health/surveys/adul-psyc-morb-res-hou-sur-eng-2007/
adul-psyc-morb-res-hou-sur-eng-2007-rep.pdf
European Union 1.7 5.2 3.4 2010 2,697,000 8,284,800 10,981,800 Own population-weighted calculation for 2010
 The red-shaded cells indicate more than 150%, the green-shaded cells 
less than 50% of the EU average (color only in online version). If both wom-
en and men have the same shading, the country name is also shaded. GSRA = 
Global Status Report on Alcohol 2004 [107]; MCSS = Multi-Country Survey 
Study [33]; WHS = World Health Survey [108]; WMHS = World Mental 
Health Survey [109]. 
1 Based on the CAGE with a criterion of at least two positive answers, 
2.2% of women 65 years and older, and 7.1% of men in that age range were 
screened for AD [110]. 2 There are several regional studies in Germany (see 
overview for studies until 2005 [14]) as well as two traditions of national sur-
veys: the German National Health Interview and Examination Survey [40] 
and German Epidemiological Survey of Substance Abuse [53]. The prior 
wave of the German National Health Interview and Examination Survey for 
Adults conducted 1997–1999 found similar data: 1.3% for women and 5.4% 
for men for the age group 18–64 [31, 32]. See text for a description of preva-
lence trends over time. 3 The Istituto Superiore di Sanita estimates the prev-
alence to be 2% overall [111]. No details about the methodology were given. 
See also [112] for a discussion of the prevalence of AD in Italy. Numbers of 
people afflicted were based on 0.45%. 4 The prevalence of abuse was found 
to be 5 times higher. AUDs as the sum of AD and abuse have been stable for 
the past decade [54], but AD estimates had been considerably higher in the 
preceding survey [58]. 5 The prevalence of AD in primary healthcare was 
found to be 19% using the CAGE screening scale [113]. 6 The national survey 
for 2012 found a prevalence of 0.3% for AD based on AUDIT thresholds in 
the age group 15–74 [114]. 7 The Part Study showed 3.3% for women and 
7.7% for men [see 14, 115; see also 116]. 8 There are other estimates such as 
the one cited by the National Institute for Health and Clinical Excellence 
[117], which amounted to 6% of men and 2% of women. The prevalence for 
Northern Ireland was substantially lower in 1993/1994 (1.4% for both sexes 
[118]). There is another study on Northern Ireland as part of the WMHS 
(field work 2004–2008) which showed a prevalence rate of 4.2% when ad-
justed for independent assessment of abuse and dependence [119].
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 [39] ) were provided, we used the age structure of an adjacent coun-
try with a similar drinking pattern to estimate the prevalence 
of AD for people 18–64 years of age (for example, in the case of 
Austria, we used the German survey  [40] ).
 Countries and Regions Examined 
 The prevalence of AD was examined for the 2010 members of the 
EU and for Iceland, Norway, and Switzerland. Regions used in this 
analysis were defined as follows: Central-West and Western Europe 
(Austria, Belgium, France, Germany, Ireland, Luxembourg, the 
 Netherlands, Switzerland, and the United Kingdom); Central-East 
and Eastern Europe (Bulgaria, Czech Republic, Estonia, Hungary, 
Latvia, Lithuania, Poland, Romania, Slovakia, and Slovenia); South-
ern Europe (Cyprus, Greece, Italy, Malta, Portugal, and Spain), and 
Nordic countries (Denmark, Finland, Iceland, Norway, and Sweden).
 Modelling the Associations between Alcohol Dependence and 
Various Measures 
 The following factors were tested for association with gender-
specific AD rates: gross domestic product per capita adjusted for 
purchasing power parity (GDP-PPP), adult per capita total con-
sumption of alcohol, patterns of drinking scores, liver cirrhosis 
mortality, injury mortality, and alcohol-attributable mortality.
 GDP-PPP data for 2010 were obtained from the World Eco-
nomic Outlook Database of the International Monetary Fund  [41] . 
Adult per capita consumption of alcohol was composed of record-
ed, tourist, and unrecorded consumption. Data on per capita con-
sumption were obtained from the WHO Regional Office for 
Health (for the databank and definitions, see http://www.euro.
who.int/en/what-we-do/data-and-evidence/databases/european-
health-for-all-database-hfa-db2, and  [42] ). Data were for 2010 and 
identical to data from the WHO in the Global Information System 
for Alcohol and Health (GISAH) (http://www.who.int/gho/ 
alcohol/en/index.html). The proportion of unrecorded consump-
tion in Europe to total per capita consumption was found to be 
lower than the global estimates (see  [42] ; for a general discussion 
of the term, see  [43] ). The pattern of drinking score is a population 
summary measure that indicates how alcohol is consumed. It is 
comprised of four indicators of heavy drinking occasions and in-
toxication, one measure of drinking in public places, and one mea-
sure of drinking with meals  [44, 45] . Patterns of drinking scores 
were obtained from the GISAH. The prevalence of heavy drinking, 
defined as 60 g and more of ethanol/day for men or 40 g and more 
for women (for the thresholds in the definition, see  [49] ) was esti-
mated using the methodology developed for the CRA  [46–48] and 
was calculated using data on per capita consumption and lifetime 
abstention obtained from the GISAH. Alcohol-attributable mor-
tality (using the categories of liver cirrhosis, cancer, and injury) 
were obtained from a WHO European region publication  [50] .
 All associations were modeled using Pearson product-moment 
correlation coefficients using the statistical software package R 
(version 3.0.1)  [51] .
 Results 
 Based on data from population studies, close to 11 
million (10.98) adults 18–64 years of age were estimated 
to be alcohol-dependent in the EU in 2010, with approx-
imately 3 times more men than women being alcohol-
dependent (see  table 1 for details). Adding AD estimates 
for Iceland, Norway, and Switzerland to the EU esti-
mates, the total number of individuals who were alcohol-
dependent increased to 11.36 million; however, the un-
derlying prevalence of AD did not noticeably change. 
The main results of the review are summarized in  table 1 , 
showing a lack of quality data as defined by the highest 
priority.
 The overall prevalence of alcohol abuse including all 
comparable ages was approximately equal to the preva-
lence of AD (lower prevalence of abuse: Germany  [40] , 
Norway Oslo  [52] ; about the same, ±0.3%: Germany  [53] ; 
higher prevalence of abuse: the Netherlands  [54] , Norway 
rural  [52] ; in Slovakia, in the WHO multi-country study 
 [33] , women had a higher prevalence of alcohol abuse 
and men had a higher prevalence of AD). These results 
included only studies that independently measured AD 
and alcohol abuse, so the WMHS results were excluded 
since dependence in those surveys was only assessed if 
there was at least one symptom of abuse. The observation 
of approximately equal prevalence of AD and alcohol 
abuse was corroborated by earlier European studies (list-
ed in  [14] ).
 In terms of age, the proportion of abuse among all 
AUDs is larger in young adults  [14] , which is consistent 
with the assertion that more severe AD can be observed 
in later age groups  [55] . Overall, among people 18–64 
years of age, we estimate that approximately 23 million 
people in our studied countries have an AUD, as defined 
by AD or abuse/harmful use.
 Trends in the Prevalence of Alcohol Use Disorders over 
Time 
 Data on AD that are comparable over time were available 
for only a few countries, and often based on screening scales 
or other more indirect measures for AUDs. For  Belgium, 
the National Health Interview Survey used the CAGE 
screener as a comparable indicator; according to the CAGE 
screener, the prevalence of AUDs increased among women 
(6.6, 7.8, and 10.2% for 2001, 2004, and 2008, respectively), 
and among men (9.2, 10.5, and 13.1% for 2001, 2004, and 
2008, respectively)  [56] . Additionally, between 2001 and 
2008, an increase in the prevalence of AUDs defined 
by CAGE was observed for all age groups for both women 
and men (https://www.wiv-isp.be/scripts92/broker.exe?_ 
service = default&_program = phisia.alcohol08.sas).
 In Germany, data on AUDs based on DSM-IV diag-
nostic criteria and a standardized methodology  [57] have 
been available since 1997, allowing for comparisons over 
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time. Within the German Epidemiological Survey of Sub-
stance Abuse, AUD criteria were assessed using the Mu-
nich Composite International Diagnostic Interview (M-
CIDI). AD was measured in 1997, 2000, 2006, and 2012, 
and comparisons can be made for both sexes for people 
18–59 years of age  [53] . Twelve-month prevalence esti-
mates revealed a significant increase in the prevalence of 
AD in men between 2006 (4.0%) and 2012 (5.2%), with a 
constant prevalence in the previous surveys before 2006. 
Similarly, a significant increase in the rate of AD in fe-
males can be observed between 2006 (1.5%) and 2012 
(2.1%). Rates in 1995 and 2000 were 1.0 and 1.2%, respec-
tively. For alcohol abuse, the data were relatively stable, 
with the prevalence of abuse being higher overall than the 
prevalence of AD  [53, 57] . Thus, for the period of 1995–
2012, the data suggest an increase in the number and rate 
of people with AD (and AUD) in the general population 
in Germany.
 For the Netherlands, the prevalence of AUDs did not 
change between 1996 and 2009  [54] when the values from 
1996 were statistically adjusted for differences in the diag-
nostic instrument and CIDI version used. However, AD 
seems to have decreased from 4.3 to 0.7%  [54, 58] . This 
decrease may be explained by the use of the WMHS pro-
cedure of asking dependence questions only of those peo-
ple who answer affirmatively to abuse questions; however, 
the description of the exact methodology used was unclear 
 [54] , and thus we did not adjust the 2009 prevalence. For 
Switzerland, only comparisons based on different versions 
of the AUDIT were available (versions differing in the op-
erationalization of the consumption questions), and they 
seem to indicate stability of prevalence of people with an 
AUDIT score of 16 and more between 1997 and 2012 (all 
prevalence below 1%  [59, 60] ). Overall, for those countries 
with comparable assessments, the prevalence of AUDs 
seemed to remain stable or may be increasing. However, 
the lack of studies with comparable quality indicators was 
even more apparent for trends than for rates.
 Associations between the Prevalence of Alcohol 
Dependence and Hypothesized Correlates 
 Corroborating the results of the last review  [14] , pat-
terns of drinking scores had the highest level of associa-
tion with the prevalence of AD among men; however, this 
association was not significant for women. In contrast, 
the measures of per capita total and unrecorded con-
sumption of alcohol and the prevalence of heavy alcohol 
consumption were found to be not significantly associ-
ated with the prevalence of AD for either men or women. 
A significant association was found between the preva-
lence of AD and injury mortality for women (a non-sig-
nificant association was observed for men); however, the 
associations between liver cirrhosis mortality and all al-
cohol-attributable deaths (liver cirrhosis, cancer and in-
jury) and AD were not significant for either women or 
men. Additionally, the economic wealth of a country in 
Europe (measured as GDP-PPP) had no association with 
the prevalence of AD for either men or women.  Table 2 
outlines the associations between the prevalence of AD 
and the hypothesized correlates for women, men, and the 
total population.
 Heavy Drinking and Alcohol Dependence 
 Figures 1 and  2 outline the prevalence of AD and heavy 
alcohol consumption by region in Europe in 2010 for 
women and men 18–64 years of age respectively. In 2010 
 Table 2.  Correlations between the prevalence of AD and variables hypothesized to be associated with AD (EU countries, Iceland, 
Norway, and Switzerland, 2010)
Women Men Total
r1 95% CI p value r1 95% CI p value r1 95% CI p value
Gross domestic product (purchasing power parity) 0.07 –0.30–0.42 0.710 –0.22 –0.54–0.15 0.245 –0.16 –0.49–0.21 0.404
Per capita consumption 0.17 –0.21–0.50 0.383 0.25 –0.12–0.56 0.179 0.24 –0.13–0.56 0.192
Unrecorded consumption2 –0.02 –0.38–0.34 0.922 –0.06 –0.41–0.31 0.772 –0.06 –0.41–0.31 0.763
Patterns of drinking score3 0.27 –0.10–0.58 0.145 0.63 0.35–0.81 0.000 0.59 0.29–0.78 0.001
Prevalence of heavy alcohol consumption4 0.24 –0.13–0.55 0.199 0.18 –0.19–0.51 0.333 0.23 –0.14–0.55 0.219
Liver cirrhosis mortality 0.08 –0.33–0.46 0.713 0.25 –0.16–0.59 0.234 0.21 –0.21–0.56 0.324
Injury mortality 0.62 0.30–0.82 0.001 0.39 0.01–0.68 0.054 0.45 0.07–0.72 0.024
Alcohol-attributable liver cirrhosis, cancer and injury deaths 0.21 –0.20–0.56 0.304 0.47 0.09–0.73 0.018 0.39 0.00–0.68 0.053
 1 Pearson product-moment correlation coefficients. 2 Unrecorded consumption in liters adult per capita (see above and WHO [21]). 3 Pattern of drink-
ing score (see Methods above and Rehm et al. [44, 120]). 4 On average a consumption of alcohol ≥60 g/day for men and 40 g/day for women.
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in the EU, 3.5% of people 18–64 years of age were esti-
mated to be alcohol-dependent, while 11.1% were esti-
mated as heavy drinkers. The ratio of people who were 
alcohol-dependent as compared to the number of people 
who were heavy drinkers varied by sex and region. For 
men in the EU in 2010 the prevalence of heavy drinking 
was 2.7 times the prevalence of AD, while for women the 
prevalence of heavy drinking was 4.9 times the prevalence 
of AD. Within Europe, the South had the highest ratio, 
with the prevalence of heavy drinking being 8.1 times the 
prevalence of AD, while Nordic countries had the lowest 
ratio, with the prevalence of heavy drinking being 1.9 
times the prevalence of AD.
 Discussion 
 This study found that AD and AUDs are common in 
the EU. We estimated that in 2010 approximately 11 mil-
lion adults in the EU were alcohol-dependent and that 
 Fig. 1. Prevalence of alcohol dependence 
and heavy alcohol consumption (40+ g of 
ethanol/day) in Europe by region in 2010 
for women. 
 Fig. 2. Prevalence of alcohol dependence 
and heavy alcohol consumption (60+ g of 
ethanol/day) in Europe by region in 2010 
for men. 
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more than 22 million adults in the EU qualified as having 
AUDs. The AUD estimates may become important when 
systems of care shift to treatments in accordance with the 
DSM-5  [61] . The prevalence of alcohol abuse was higher 
in young adults  [14] , which is consistent with the notion 
that more severe AD was found in the later age groups  [9, 
55] .
 The prevalence figures for AD presented in this paper 
may be underestimated as they are derived from general 
population surveys which do not include special and mar-
ginalized groups such as the homeless, people who are 
incarcerated, and people who are institutionalized  [62] . 
In marginalized groups, heavier drinking patterns and a 
markedly higher prevalence of AD and AUDs are com-
mon. For example, in a systematic review of mental illness 
among homeless men in Western societies, Fazel et al. 
 [63] found a pooled prevalence estimate of 38% for AD, 
with two factors being associated with the heterogeneity 
across studies: the more recent the study (as analyzed by 
decade), the higher the prevalence of AD, and studies 
from mainland Europe showed a higher prevalence of 
AD. For instance, two German studies observed a preva-
lence of AD that exceeded 50% among the homeless  [64, 
65] , and in Ireland alcohol was found to be the most prev-
alent drug among the homeless, with alcohol problem 
rates above 70% as measured with the AUDIT  [66] . Fur-
thermore, in the Irish study, 13% of respondents named 
alcohol problems as the main reason for them becoming 
homeless.
 AD has also been found to be highly prevalent in in-
carcerated populations  [67] . In their systematic review, 
Fazel et al.  [67] found that the prevalence for alcohol 
abuse and AD among males who were incarcerated 
ranged from 18 to 30%, and ranged from 10 to 24% among 
females who were incarcerated. Additionally, in a repre-
sentative study of Irish males who were incarcerated re-
mand, a 6-month prevalence of 28.8% for AD and 39.3% 
for AUDs was observed (alcohol abuse and AD were de-
fined to be exclusive  [68] ). In two English prisons in 2003, 
the prevalence of AD was 57% among men  [69] . In a 
Greek prison, 37.5% of a randomly drawn sample of male 
inmates were diagnosed as having AD  [70] . In a study of 
male inmates of a French prison in 2004, 19% were alco-
hol-dependent  [71] .
 It has been observed in numerous studies that AD and 
AUDs show a high comorbidity with somatic and mental 
disorders, and thus are significantly more prevalent in 
both acute and psychiatric hospital wards  [72, 73] .
 Thus, in specialized and marginalized populations not 
covered in surveys there is a much higher prevalence of 
AD and AUDs when compared to the general popula-
tion. This indicates that the prevalence figures presented 
in our paper markedly underestimate the true preva-
lence; however, additional research is needed on the ex-
act size of homeless, incarcerated and other institutional-
ized populations in various European countries to deter-
mine the extent of the underestimation of the population 
prevalence of AD. It is conceivable that this underestima-
tion may be substantial  [74] . In their working document 
titled ‘Confronting Homelessness in the European 
Union’ (http://ec.europa.eu/social/BlobServlet?docId  = 
9770&langId = en), the EU referred to 410,000 homeless 
people (defined as being without a house or a roof on any 
given night in the EU). This could imply that about 4.1 
million people in the EU are exposed to rooflessness and 
houselessness over the span of 1 year for a shorter or lon-
ger period (calculations consistent with being based on 
‘any’ night, combined with assumptions on the length of 
homelessness). Based on this prevalence, the overall 
number of people with AD in the EU would increase by 
an additional 1.5 million if homeless people were ac-
counted for in the surveys. The additional numbers com-
ing from incarcerated people would be comparatively 
lower, with about 200,000 additional people with AUD 
(based on the meta-analyses above and incarceration 
rates from http://www.nationmaster.com/country-info/
stats/Crime/Prisoners/Per-capita).
 We also hypothesize that marginalized populations 
overproportionally contribute to the harms which result 
from AD and AUDs, illustrated, for example, by the high 
standardized mortality rates associated with people with 
AD in treatment compared to the general population  [7] . 
This finding may be the result of including some margin-
alized groups in treatment programs.
 With respect to the associations examined in this pa-
per, we found no association of AD with wealth at the 
between country level; however, this observation was ex-
pected as the strong correlations between economic 
wealth and alcohol consumption are restricted to low- 
and middle-income countries  [75, 76] . We would have 
expected much stronger correlations of AD with both al-
cohol exposure (heavy drinking) and especially outcome 
(liver cirrhosis, injury). Additionally, heavy drinking is 
not included in the definition of AD and AUDs, as these 
are defined and measured by a number of criteria, some 
of which are based on loss of control, as specified in the 
ICD-10 or DSM IV (see above). It should be noted, how-
ever, that loss of control is perceived differently in differ-
ent cultures  [77, 78] , which may seriously distort the rela-
tions with other variables. Where loss of control is stig-
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matized in countries like Italy, Spain, and France, in 
Nordic or Central Eastern European countries loss of 
control may be one of the reasons why people drink. 
Thus, ‘admitting’ to losing control equates in some coun-
tries to a statement that people had a good time, while for 
countries in the South or Central West of Europe such an 
admission is perceived as a weakness. We believe that 
these cultural differences are at the core of the multifold 
differences in the prevalence of AD between these re-
gions  [79] . Accordingly, it seems that AUD prevalence is 
very culture-specific, and thus correlations with other 
health indicators are biased downwards because of the 
high culture-specific variability. Heavy drinking rates 
may be the better indicator for public health and health-
care planning  [11, 79, 80] . Other factors contributing to 
the low prevalence of AUDs in the South of Europe may 
be lack of training in physicians, leading to perceptions 
that some less severe AUDs may be ‘normal drinking’ 
 [81] .
 Additionally, other alcohol-related, genetic, and social 
factors, such as alcohol excise prices, taxation rates and 
taxation types  [82] , alcohol availability  [83, 84] , alcohol 
marketing policies  [85] , prevalence of people with vari-
ants in the genes that metabolize alcohol such as  ALDH2 
 [86] , prevalence of various religions  [87] , emancipation 
of women  [88] , and unemployment rates  [89] , have also 
been hypothesized to be causally related to alcohol con-
sumption and/or AD rates. In future studies associations 
with these variables should be explored.
 Other limitations of our work include measurement 
errors stemming from the different operationalizations 
of AD and AUDs in different countries ( table 1 ). Thus, it 
is not only the different cultures which impact on an-
swers to assessment instruments. There are also substan-
tial differences in how AD is measured, from the Statisti-
cal Office making estimations based on the liver cirrhosis 
rate in Hungary, to various assessments in different 
countries using variants of the CIDI, and a variety of op-
erationalizations in between ( table 1 ). Multifold differ-
ences can result from only asking questions on AD of 
people who show at least one criterion of abuse. More-
over, the variants of the CIDI are different with respect 
to who will be asked any question on AUDs (e.g. all 
drinkers or all drinkers who consumed above a thresh-
old). These different operationalizations create biases, 
which are reflected in the final comparisons. Additional 
systematic work on assessing AUDs may necessary to be 
able to compare the prevalence of AUDs in European 
countries, e.g. a comparative survey in the EU using stan-
dardized methodology.
 However, given the cultural specificity of criteria and 
the relatively low correlations with outcomes, it may be 
more advisable to invest into better ways to compara-
tively measure heavy drinking. Heavy drinking over 
time may be a better indicator for what we currently call 
an AUD, as it is better linked to biological and biochem-
ical definitions as a brain disease, as well as to health and 
social outcomes  [79, 80] . As an example from the data-
set we used in this study, AD prevalence was associated 
with liver cirrhosis, one of the main outcomes of AD, 
with Pearson correlations of r = 0.08 for women, and r = 
0.25 for men; the associations of AD with heavy drink-
ing were r = 0.57 for women and r = 0.58 for men. Rely-
ing on heavy drinking as the best definition may also 
reduce the very high stigmatization of AD  [90] , as it 
could be handled similarly to continuous indicators such 
as blood pressure (for the association between continu-
ous indicators and stigma, see  [91] ), and different inter-
ventions could be planned to reduce drinking without 
necessarily involving a label such as dependence or ad-
diction  [79, 92] . Of primary importance is that reducing 
drinking has been shown as an effective form of treat-
ment for AD, and has been linked to reductions in mor-
tality and disability as well as to reductions in social 
harms  [79, 93] .
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